MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Other current assets$192,349K Manufacturing-related deposits andprepaids$206,062K Inventory$1,077,166K Accounts receivable, net$395,739K Short-term investments$237,916K Cash and cashequivalents$613,077K Other non-currentassets$73,384K Non-current investments$1,040K Non-current inventory$198,601K Right of use assets$139,167K Property and equipment,net$358,936K Total current assets$2,722,309K Total assets$3,493,437K Total liabilities andstockholders equity$3,493,437K Total stockholdersequity$1,320,120K Total liabilities$2,173,317K Accumulated deficit-$4,641,537K Treasury stock, at cost,650,876 and 0 shares at...$25,263K Accumulated othercomprehensive loss, net of tax$220K Additional paid-in capital$5,986,689K Other non-currentliabilities$1,404K Contingent consideration,net of current...$300K Lease liabilities,net of current...$215,042K Long-term debt$1,035,146K Total currentliabilities$921,425K Common stock, 0.0001par value,...$11K Other currentliabilities$10,168K Contingent consideration,current portion$36,000K Deferred revenue,current portion$485,449K Accrued expenses$295,793K Accounts payable$94,015K
Balance Sheet
source: myfinsight.com
logo (1) copy-svg

Sarepta Therapeutics, Inc. (SRPT)

logo (1) copy-svg

Sarepta Therapeutics, Inc. (SRPT)